Search

everythinglearnresearchcommunity

for

Search:↓

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Mast cells likely promote skin scarring and fibrosis, but their exact role is still unclear.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Understanding chaos and control mechanisms in disease can improve diagnosis and prediction in medicine.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

A patient developed a blister at the injection site after hepatitis C treatment.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

Skin ulcers from interferon may not depend on the amount given.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.